Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

9317 results about "Tumor cells" patented technology

Tumors are made up of extra cells. Normally, cells grow and divide to form new cells as your body needs them. When cells grow old, they die, and new cells take their place. Sometimes, this process goes wrong.

Application of PARPi sensitizer in treatment of malignant tumors

ActiveCN119185316AOrganic active ingredientsMicrobiological testing/measurementNon malignantSynthetic lethality
The invention provides application of a PARPi sensitizer in treatment of malignant tumors, and particularly relates to the technical field of biological medicines. A large number of experiments prove that TRMT10A is crucial for recruitment from BRCA1 to DNA damage sites for the first time, so that HR repair is promoted. The deletion of TRMT10A inhibits HR repair, so that tumor cells are more sensitive to PARPi. The invention discloses that the expression of TRMT10A in mCRPC is up-regulated, and the TRMT10A is regulated and controlled by ubiquitin specific peptidase 10 (USP10). Spautin-1 significantly results in the deficiency of TRMT10A, and sensitizes the tumor to PARPi in both patient-derived xenograft (PDX) and cell-derived xenograft (CDX). The research reveals that the ATM-TRMT10A-BRCA1 axis plays an important role in sensibilization of the PARP inhibitor, and a new angle is provided for exploring synthesis lethality. The mechanism can be therapeutically utilized through the combination of PARPi and Spautin-1, which may benefit more extensive patients with non-BRCA malignant tumors, and has important clinical significance.
Owner:CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI

Thiazolidinedione compound containing quinoline structure and application of thiazolidinedione compound

The invention relates to the field of medicinal chemistry, in particular to thiazolidinedione compounds containing quinoline structures and application of the thiazolidinedione compounds. The compound can influence the interaction between KRAS and downstream protein cRaf, namely indirectly inhibits the function of KRAS, and further inhibits the proliferation of tumor cells, and the compound and the pharmaceutical preparation thereof can be used for treating a series of diseases caused by KRAS dysfunction, mainly KRASG12D related cancers, such as KRASG12D related cancers, KRASG12D related cancers, KRASG12D related cancers, KRASG12D related cancers, KRASG12D related cancers, KRASG12D related cancers, for example, colon cancer, rectal cancer, pancreatic cancer, lung cancer, endometrial cancer, skin cancer and the like.
Owner:SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI

Pharmaceutical composition of KRAS G12C inhibitor and camptothecin and application thereof

The invention relates to the field of antitumor drugs, in particular to a pharmaceutical composition of a KRAS G12C inhibitor and camptothecin and application of the pharmaceutical composition. The camptothecin and the KRAS G12C inhibitor are combined to play a synergistic effect, a DNA damage repair pathway is inhibited, a better inhibition effect is generated on tumor cells containing KRAS G12C mutation, the dosage required for achieving the same anti-tumor effect is greatly reduced, and the medication safety is improved.
Owner:FUJIAN MEDICAL UNIV UNION HOSPITAL +1

Pharmaceutical composition of KRAS G12C inhibitor and Ly2090314 and application thereof

The invention relates to the field of antitumor drugs, in particular to a pharmaceutical composition of a KRAS G12C inhibitor and Ly2090314 and application of the pharmaceutical composition. According to the invention, the Ly2090314 and the KRAS G12C inhibitor are combined to play a synergistic effect, a DNA damage repair pathway is inhibited, a better inhibition effect is generated on tumor cells containing KRAS G12C mutation, the dosage required for achieving the same anti-tumor effect is greatly reduced, and the medication safety is improved.
Owner:FUJIAN MEDICAL UNIV UNION HOSPITAL +1

Targeting RAS-Raf protein interaction stapled peptide and application thereof in antitumor drugs

The invention relates to the field of biological medicine, in particular to a stapled peptide targeting RAS-Raf protein interaction and application of the stapled peptide, the stapled peptide is obtained in the mode that Ac-SLHDCLMKALKVR-NH2 and Ac-SLHDCLMKALKVRGL-NH2 serve as peptide chain templates, amino acid at the i site and amino acid at the (i + 4) site are replaced with S5 and cyclized, and the nitrogen terminal is further modified with stearic acid. The stapled peptide can effectively inhibit proliferation and migration of tumor cells; the serum stability is high, and meanwhile, the cell transmembrane capability is excellent, so that target protein in cells can be better targeted, and the biological function of the target protein can be exerted. Therefore, the alphaH helical conformation of the RBD of the RAF can be stabilized through the stapled peptide and a nitrogen-terminal fatty acid modification strategy, the membrane permeability and stability of the RAF are improved, the binding force of the RAF and RAS is further improved, and proliferation and migration of various tumor cells are inhibited.
Owner:THE NAVAL MEDICAL UNIV OF PLA

Circulating tumor cell recognition model training method and system based on deep learning

The invention provides a circulating tumor cell recognition model training method and system based on deep learning, and the method comprises the steps: obtaining a multi-channel pathological sample image set of circulating tumor cells, carrying out the cross-modal feature extraction of a multi-channel pathological sample image, generating a fusion feature vector containing the morphological features and microenvironment features of the cells, and carrying out the recognition of the circulating tumor cells through the fusion feature vector. A deep convolutional network with a multi-stage training strategy is constructed, network parameters of the deep convolutional network in the training process are verified and adjusted by adopting a hierarchical cross validation mechanism, and finally a final recognition model is generated based on the verified and adjusted network parameters. The final recognition model is configured to receive the clinical pathology image stream and output localization coordinates and classification confidence of circulating tumor cells. According to the method, a circulating tumor cell recognition result can conform to a cell space distribution rule and has clinical pathological diagnosis interpretability, and the problems of high false positive rate and insufficient cell subtype discrimination caused by neglecting of microenvironment interaction in a traditional method are solved.
Owner:363 HOSPITAL

Quinazoline compound, and pharmaceutical composition thereof and use thereof

Disclosed in the present invention are a quinazoline compound, and a pharmaceutical composition thereof and the use thereof. Provided in the present invention is a compound as represented by formula I, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. The compounds of the present invention have a good degradation effect on the KRAS protein with a G12D mutation, have a good inhibitory activity against the proliferation of tumor cells with a KRAS G12D mutation, and exhibit good pharmacokinetic properties.
Owner:HANGZHOU POLYMED BIOPHARMACEUTICALS INC

Metal polyphenol network coated calcium peroxide nanoparticles as well as preparation method and application thereof

The invention provides metal polyphenol network coated calcium peroxide nanoparticles as well as a preparation method and application thereof, and belongs to the technical field of tumor treatment. According to the invention, the metal polyphenol coated calcium peroxide nanoparticles play a role in protecting the unstable calcium peroxide nanoparticles; released metal ions catalyze hydrogen peroxide to generate hydroxyl radicals under an acidic condition, so that tumor cells are killed, chemical kinetic treatment is realized, glutathione can be consumed, accumulation of active oxygen is enhanced, and the anti-tumor curative effect is enhanced; when the calcium peroxide nanoparticles are dispersed in an acid environment, a metal polyphenol network layer can be rapidly degraded, the calcium peroxide nanoparticles are exposed, and then a large amount of calcium ions and oxygen are released in a blasting manner, so that calcium overload can be more effectively activated, and a tumor hypoxic microenvironment can be more effectively relieved; by loading the medicine, the effective accumulation of the medicine at a tumor part is improved, and the combined treatment of chemical kinetics treatment and chemotherapy is realized, so that the anti-tumor immune response is activated, and the anti-tumor effect is improved.
Owner:HENAN UNIV OF CHINESE MEDICINE

Double-layer microneedle patch and preparation method thereof

The invention discloses a double-layer microneedle patch and a preparation method thereof.The preparation method of the double-layer microneedle patch comprises the following steps that firstly, 3D printing is conducted through polydimethylsiloxane, and a PDMS mold similar to a machining microneedle is obtained; dispersing the medicine into the sericin solution to serve as an outer layer solution; dispersing germanium nanoparticles into the polycaprolactone solution to obtain an inner layer solution; and finally, adding the outer-layer solution into the needle-shaped groove of the PDMS mold, so that the needle-shaped groove is filled with the outer-layer solution, drying, adding the inner-layer solution, drying, and demolding to obtain the double-layer microneedle patch. When the double-layer microneedle patch is used for drug delivery, drugs can be dissolved and released in a short time, the inner layer is polycaprolactone (PCL) carrying photo-thermal agent germanium nanoparticles, degradation is slow, a photo-thermal effect is generated under irradiation of 808nm near-infrared light, residual tumor cells are induced to die immunogenicity, an immune microenvironment is programmed in a time sequence, and the double-layer microneedle patch has the advantages of being high in sensitivity, high in sensitivity and good in stability. Postoperative recurrence and metastasis of tumors are efficiently inhibited, and meanwhile operative wound repair is promoted.
Owner:XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV

Targeting ligands for disease-targeted imaging agents and methods of use therefor

In accordance with at least one aspect of this disclosure, there is provided an imaging agent, a including dye compound conjugated to an antigen specific targeting vector which can be particularly advantageous because their behavior in vivo can contribute to superior optical imaging properties, for example, by significantly increasing the target-to-background ratio of imaged tissues, leading to higher resolution imaging, and ultimately providing for better recognition of malignant tissue for resection and margin assessment and improved visualization during minimal invasive laparoscopic surgery, for example. A method of imaging tumor cells in a subject, can include, administering an imaging effective amount of an imaging agent according at least one embodiment of the invention; 2-4 hours after administration of the imaging agent, irradiating a region in the subject in which tumor cells are expected to be found with at a wavelength absorbed by the imaging agent; and detecting a signal from the imaging agent, thereby imaging the tumor cells, wherein the target-to-background ratio 2-4 hours after administration is from about 2.75 to about 15.
Owner:CURADEL SURGICAL INNOVATIONS INC

Colorectal cancer drug relocation method based on multi-omics integration

The invention discloses a colorectal cancer drug relocation method based on multi-omics integration. The system comprises a multi-omics data acquisition and preprocessing module, a tumor microenvironment analysis module, a specific disease network construction module, a multi-dimensional drug relocation module and a result evaluation module. And the tumor microenvironment analysis module comprises cell heterogeneity identification, cell map construction, cell annotation and tumor cell subset annotation. The specific disease network construction module comprises tumor feature expression program extraction, expression program screening, meta-program construction, clinical related meta-program recognition and specific disease protein interaction network construction. And the multi-dimensional drug relocation module comprises a module for identifying diseases by using a random walk algorithm, carrying out drug screening based on disturbance data, carrying out drug screening based on network proximity and carrying out comprehensive drug relocation. From the perspective of single cell data, element programs related to colorectal cancer survival are excavated, corresponding modules are designed, and the efficiency and precision of colorectal cancer targeted drug screening are improved.
Owner:HANGZHOU NORMAL UNIVERSITY

Nano system for tumor radioimmunotherapy and preparation method and application thereof

The invention discloses a nano system for tumor radioimmunotherapy and a preparation method and application thereof, and belongs to the technical field of biological medicines.The system modifies bacteria outer membrane vesicles (OMVs) through engineering to enable the bacteria outer membrane vesicles to carry magnetite nanoparticles (Fe3O4NPs) and an ATR inhibitor VE822, the Fenton reaction activity of the Fe3O4NPs and the synergistic effect of the ATR inhibitor for inhibiting DNA damage repair are utilized, and the tumor radioimmunotherapy effect is improved. DNA damage is amplified, DNA damage reaction (DDR) is inhibited, generation of hydroxyl radicals (. OH) under radiation is enhanced, radiation resistance of tumor cells is reduced, immune reaction is reactivated, infiltration of effector T cells to tumors is improved, growth of mice tumors is remarkably inhibited, and an effective strategy is provided for tumor radioimmunotherapy.
Owner:ANHUI PROVINCIAL HOSPITAL

Anti-CEACAM5 and CEACAM6 antibody and application thereof

According to the present invention, the anti-CEACAM5 and CEACAM6 antibody or the antigen binding fragment thereof and the use thereof are provided, the antibody is the anti-CEACAM5 and CEACAM6 antibody with good performance, and can simultaneously bind the target spots of CEACAM5 and CEACAM6 with high affinity and specificity so as to enlarge the adaptation disease of the antibody; the anti-CEACAM5 and CEACAM6 antibody has combination difference, is almost not combined with normal cells, and is only combined with overexpressed tumor cells, so that adverse effects caused by non-specific combination are reduced. The antibody also has good endocytosis activity, and can be used for coupling a cytotoxic drug to form an antibody drug conjugate for anti-tumor therapy.
Owner:SHENGHE CHINA BIOPHARMACEUTICAL CO LTD

AIE type fluorescent probe with tumor targeting property as well as preparation and application of AIE type fluorescent probe

The invention discloses an AIE type fluorescent probe with tumor targeting as well as preparation and application thereof, and belongs to the technical field of medicines, the probe can accurately target HDAC6 high-expression tumor cells, the specific binding capacity of the probe reduces interference to normal cells, and the detection accuracy is improved. The probe is fused with AIE performance dye molecules and emits strong fluorescence during aggregation, so that the imaging sensitivity and definition are remarkably enhanced. By optimizing the structure and synthesis conditions, the fluorescence intensity and stability of the probe are improved, the sensitivity of early tumor detection is ensured, and the survival rate and life quality of patients are improved. The preparation method is simple, convenient, feasible, low in cost and beneficial to practical application. The probe can be used for preparing tumor detection products, assisting in tumor diagnosis and classification, monitoring treatment changes and evaluating the curative effect. High-precision imaging can be realized in the aspect of tumor imaging, the method can be used for evaluating curative effect and guiding formulation of subsequent treatment schemes, and the application prospect is wide.
Owner:XIDIAN UNIV

Tumor cholesterol metabolism regulation microneedle patch and preparation method thereof

The invention discloses a tumor cholesterol metabolism regulation microneedle patch and a preparation method, the microneedle patch comprises a needle tip and a backing which are connected, the needle tip comprises a needle tip body and nanoparticles loaded on the needle tip body, the nanoparticle is a manganese ion-doped organic metal framework, the outer layer of the manganese ion-doped organic metal framework is modified with a targeting agent, cholesterol oxidase and superoxide dismutase are carried on the manganese ion-doped organic metal framework, the targeting agent can target a CD44 receptor, and the organic metal framework can carry drugs. The targeted drug can enter tumor cells in a targeted mode, superoxide dismutase catalyzes superoxide anions overexpressed in the tumor cells to generate H2O2 and O2, O2 needed by catalysis is provided for cholesterol oxidase, cholesterol at the tumor site is consumed by the cholesterol oxidase, accumulation of 7-DHC is reduced, meanwhile H2O2 can be generated, and the cholesterol oxidase can be used for catalyzing the tumor site. H2O2 is catalyzed by manganese ions through a Fenton-like reaction to generate OH to induce tumor cells to generate ferroptosis, so that ferroptosis-immune synergistic treatment is realized.
Owner:SOUTHWEST JIAOTONG UNIV

Application of reagent for targeted inhibition of circPDK1 in preparation of anti-esophageal cancer drugs

The invention relates to application of a targeted inhibition circPDK1 reagent in preparation of an anti-esophageal cancer drug, and belongs to the field of biological medicines. The reagent for targeted inhibition of circPDK1 expression provided by the invention is shRNA or siRNA, and in-vivo and in-vitro experiments prove that the reagent can significantly inhibit circPDK1 expression and inhibit growth and migration of esophageal cancer tumor cells; after siRNA of targeted annular circPDK1 is packaged into efficient and low-toxicity LNP-siRNA, circPDK1 expression is specifically silenced, proliferation and migration of esophageal cancer tumors can be remarkably inhibited, and a basis is provided for clinical treatment and scientific research of esophageal cancer related circRNA.
Owner:KUNMING MEDICAL UNIVERSITY

PROTACs compound for targeted degradation of PRMT5 and application of PROTACs compound

The invention discloses a PROTACs compound for targeted degradation of PRMT5 and application of the PROTACs compound. The PROTACs compound comprises a compound as shown in the following formula, and related analogues or pharmaceutically acceptable salts, metabolites or prodrugs of the compound: in the # imgabs0 # formula, X represents a ligand bound to PRMT5 protein, Z represents a ligand of E3 ubiquitin ligase, and Y represents a linking group for linking X and Z; according to the invention, CRBN is used as E3 ligase, and a series of PRMT5-targeted PROTAC degradation compounds are designed and synthesized. The compound can effectively induce PRMT5 degradation, significantly inhibit proliferation, growth, migration, infiltration, clone formation and metastasis of tumor cells, promote apoptosis of cancer cells, promote autophagy of the tumor cells, prevent or overcome drug resistance of BTK inhibitors and / or prolong the lifetime of tumor patients, and has wide application prospects.
Owner:KUNMING MEDICAL UNIVERSITY

Antibodies or antigen-binding fragments binding to NKG2a and uses thereof

Provided is an antibody or antigen-binding fragment that binds to NKG2A, and uses thereof. The antibody or antigen-binding fragment binding to NKG2A can improve the immune response and the lysis of HLA-E expressed tumor cells.
Owner:ELPISCIENCE (SUZHOU) BIOPHARMA LTD +1

Cell culture microcarrier as well as preparation method and application thereof

PendingCN119286758AFacilitate migration and growthpromote growthMicrocarriers3D cultureMetaboliteCultured cell
The invention relates to a cell culture microcarrier as well as a preparation method and application thereof. The cell culture microcarrier comprises a polymer porous microsphere with an inside-outside through pore channel structure. The cell culture micro-carrier comprises a biodegradable micro-carrier and also comprises a non-degradable micro-carrier, so that the growth of cells in the carrier is facilitated, and the mass transfer of nutrient substances and metabolites is also facilitated, thereby promoting the growth of the cells, enabling the cultured cells to keep good activity and function, and being high in proliferation efficiency; the method is suitable for three-dimensional culture of somatic cells, stem cells, tumor cells and the like.
Owner:INSTITUTE OF PROCESS ENGINEERING CHINESE ACADEMY OF SCIENCES

Anti-PD-L1 antibody coupling medicine and preparation method thereof

The invention discloses an anti-PD-L1 antibody coupling drug and a preparation method thereof, belongs to the field of biological medicines, and is used for preparing anti-cancer drugs. The antibody coupling medicine is formed by coupling an anti-PD-L1 antibody and a payload through a linker, a light chain variable region sequence of the antibody is a sequence recorded by SEQ ID NO: 1, a heavy chain variable region sequence of the antibody is a sequence recorded by SEQ ID NO: 2, the payload is an avixatecan derivative Dxd, and the ratio (DAR) of the payload to the antibody is 6-8. The antibody-conjugated drug has a better killing effect on PD-L1 positive tumor cells of human and dogs, and has fewer dimers and higher thermal stability at a high DAR value (DAR6-8), and an accelerated stability test shows that the antibody-conjugated drug has good structural stability and binding activity.
Owner:WENZHOU MEDICAL UNIV +1

BiTE for tumor targeted immunotherapy as well as preparation method and application of BiTE

The invention provides BiTE for tumor targeted immunotherapy and a preparation method and application, and relates to the technical field of biological pharmacy, the BiTE is obtained by coupling a nano antibody and fusion protein, the C terminal of the nano antibody contains an amino acid sequence SEQ ID No.3, and the BiTE has the function of targeting a human epidermal growth factor receptor on tumor cells; the fusion protein also targets a CD3 receptor on a T cell, activates the T cell, connects the T cell with a tumor cell in time and space, activates the T cell, secretes perforin and granzyme B to kill the tumor cell, and plays a role in targeted immunotherapy. The isopeptide bond is used for coupling the nano antibody and the fusion protein, coupling can be completed within 15 min, the coupling efficiency is 100%, and the in-vivo half-life period of the nano antibody can be prolonged by 6 times.
Owner:JILIN UNIVERSITY

Anti-CD3 nano antibody, anti-CD38 antibody and bispecific antibody containing anti-CD3 nano antibody and anti-CD38 antibody

The invention relates to an anti-CD3 nano antibody, an anti-CD38 antibody and a bispecific antibody containing the anti-CD3 nano antibody and the anti-CD38 antibody. According to the invention, an anti-CD3 nano antibody and an anti-CD38 monoclonal antibody are excavated and prepared, humanized design is carried out to obtain antibodies with high affinity and specificity, and different configurations of bispecific T cell conjugation antibodies targeting CD3 and CD38 are further designed, so that the CD3 and CD38 dual-specificity T cell conjugation antibodies are obtained. The antigen binding activity, the T cell-mediated tumor cell killing effect and the T cell proliferation and activation function of the antibody are systematically evaluated in vitro, and experimental results show that the T cell conjugation antibody can effectively recruit and activate T cells and has a remarkable killing effect on CD38 positive tumor cells, and it is further verified that the antibody has remarkable in-vivo anti-tumor activity and has a good application prospect. Therefore, the polypeptide has high affinity, good pharmacological characteristics and development potential.
Owner:BIOINTRON BIOLOGICAL INC

Exatecan hydroxylamine derivative and application thereof

The invention relates to a preparation method of a series of hydroxylamine structure-containing substituted exatecan derivatives and pharmaceutically acceptable salts thereof, and an application of the series of hydroxylamine structure-containing substituted exatecan derivatives and the pharmaceutically acceptable salts thereof in the anti-tumor field. The exatecan derivatives have good tumor cell growth inhibition activity, also have good cell membrane penetrating ability or side killing effect, and can be applied to treatment of tumors in a single drug, a combined drug or as a toxin component of ADC (Analog to Digital Converter).
Owner:HANGZHOU ADCORIS BIOPHARMA CO LTD

Iron sulfide nanoparticles as enzyme-mimetic nanocatalysts (nanoXcats)

The present invention relates to magnetic, catalytically active, and radiosensitizing nanoparticles (NanoXcats) and the method for their production. A method is disclosed for the production of functionalized greigite nanoparticles with a narrowband size distribution (10-30 nm) for use in multimodal cancer therapy. NanoXcats are superparamagnetic Fe3S4 nanoparticles whose surfaces are equipped with polar functional groups. The surface structures of NanoXcats are suitable for conjugation with, or for covalent or electrostatic binding of, active substances, which may be cancer drugs, cell growth inhibitors, or NO donors. Due to the EPR effect, NanoXcats are preferentially internalized by tumor cells. The targeted accumulation of NanoXcats in tumor tissue is achieved by an external inhomogeneous magnetic field. NanoXcats exhibit enhanced catalytic activity in tumor cells.The catalytic activity of intracellular NanoXcats can be triggered, controlled, and enhanced by low-dose X-rays. Surface-bound drugs are additionally activated in tumor cells by the catalytic activity of NanoXcats. NanoXcats act as superoxide dismutase, nitric oxide synthase, and Fenton catalyst. They catalyze, for example, reactions of the superoxide anion radical to hydrogen peroxide, of L-arginine to NO, and of hydrogen peroxide to the hydroxyl radical.
Owner:KRYSCHI CAROLA

Arginine methyltransferase 6 inhibitor as well as preparation method, pharmaceutical composition and application thereof

ActiveCN119080685ARegulate protein levelsHas anti-tumor cell activityOrganic chemistryAntineoplastic agentsDiseaseArginine
The invention provides an arginine methyltransferase 6 inhibitor as well as a preparation method, a pharmaceutical composition and application thereof, and relates to the technical field of biological medicines. The arginine methyltransferase 6 inhibitor provided by the invention is a new compound obtained on the basis of large-scale design, synthesis and screening, the arginine methyltransferase 6 inhibitor is different from an existing PRMTs inhibitor, the arginine methyltransferase 6 inhibitor can selectively degrade arginine methyltransferase 6, and the arginine methyltransferase 6 inhibitor can be used for preparing a PRMTs inhibitor. The protein level of the arginine methyltransferase 6 is regulated and controlled, and the arginine methyltransferase 6 has anti-tumor cell activity, can be used for preventing or treating PRMT6 expression abnormity related diseases, and provides a new choice for development and application of anti-tumor drugs. According to the preparation method of the arginine methyltransferase 6 inhibitor, the adopted raw materials are easy to obtain, the synthesis method is simple, safe, easy to implement and high in yield, and industrial production can be achieved.
Owner:SICHUAN UNIV

Predicting total nucleic acid yield and dissection boundaries for histology slides

A method for qualifying a specimen prepared on one or more hematoxylin and eosin (H&E) slides by assessing an expected yield of nucleic acids for tumor cells and providing associated unstained slides for subsequent nucleic acid analysis is provided.
Owner:TEMPUS AI INC

Antitumor nano material based on copper death promotion and preparation method and application thereof

The invention discloses an anti-tumor nano material based on copper death promotion as well as a preparation method and application of the anti-tumor nano material. The anti-tumor nano material is constructed by taking PCN-Cu as a metal organic framework compound and merging Pt nano particles with stable polyvinylpyrrolidone into the PCN-Cu, and the anti-tumor nano material is named as Pt-coated PCN-Cu. Experiments prove that the Pt-coated PCN-Cu can improve the concentration of copper ions in tumor cells, promote the lipoic acylation aggregation process of mitochondrial related proteins, promote degradation and proteotoxicity reaction of Fe-S cluster proteins and induce copper death of the tumor cells. The Pt-coated PCN-Cu has the advantages of being simple in preparation process, green, economical, low in cost, capable of being produced on a large scale and the like, has a good anti-tumor effect, expands a novel treatment mode for promoting tumor cell copper death, and provides a new technical means for tumor treatment.
Owner:TIANJIN TUMOR HOSPITAL +1

Tumor cell exosome, anti-tumor immune drug delivery system and preparation method and application of anti-tumor immune drug delivery system

The invention provides a tumor cell exosome, an anti-tumor immune drug delivery system and a preparation method and application of the anti-tumor immune drug delivery system, the tumor cell exosome is derived from starved and stimulated tumor cells, the tumor cell exosome is coated with nano drug particles for delivery, and the exosome has the effects of enhancing immune cell infiltration and remodeling an immune microenvironment; due to the homing effect of the exosome, the medicine and the exosome are more easily accumulated in the tumor, and the targeting property is improved; due to coating and camouflage of the biological membrane of the exosome membrane, the exosome membrane is prevented from being recognized, attacked and removed by an organism, and the biological safety is improved, so that the exosome and the nano-drug act on the tumor together to achieve a synergistic effect.
Owner:SUN YAT SEN UNIVERSITY CANCER CENTER (CANCER HOSPITAL AFFILIATED TO SUN YAT SEN UNIVERSITY CANCER RESEARCH INSTITUTE OF SUN YAT SEN UNIVERSITY)

Three-dimensional reconstruction method and system for tumor cell metabolite distribution based on artificial intelligence

The invention relates to the field of bioelectricity data processing, and discloses a tumor cell metabolite distribution three-dimensional reconstruction method and system based on artificial intelligence, and the method comprises the steps: collecting the multi-modal data of tumor cells, recognizing the entity elements of the tumor cells and the corresponding entity relationship from the multi-modal data, and obtaining the entity relationship of the entity elements of the tumor cells; constructing a metabolite knowledge map of the tumor cells; according to the space coordinates of the metabolites and the microenvironment characteristic data of the tumor cells, analyzing a space aggregation mode of the metabolites in the tumor cells; in combination with the spatial distribution mode and the biological metabolic pathway of the metabolites, key features of the metabolites in the tumor cells are extracted, and a metabolite distribution discrimination network of the tumor cells is established; and identifying an abnormal distribution mode of the metabolite in the tumor cells, constructing a metabolite distribution three-dimensional model of the tumor cells, and outputting a metabolite three-dimensional distribution result of the tumor cells. According to the method, the accuracy and comprehensiveness of the three-dimensional distribution result of the tumor cell metabolites can be improved.
Owner:RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Camptothecin compound, antibody drug conjugate, and preparation method therefor and use thereof

Provided are a camptothecin compound, an antibody drug conjugate, and a preparation method therefor and the use thereof. Specifically provided is a camptothecin compound as represented by formula (K) or a pharmaceutically acceptable salt thereof. The provided camptothecin compound and the antibody drug conjugate thereof have a good cytotoxic activity and can inhibit the proliferation of tumor cells.
Owner:SHANGHAI PHARMACEUTICALS HOLDING CO LTD